6-532589-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018303.6(EXOC2):āc.2260G>Cā(p.Glu754Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000009 in 1,444,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018303.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOC2 | NM_018303.6 | c.2260G>C | p.Glu754Gln | missense_variant | 23/28 | ENST00000230449.9 | NP_060773.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXOC2 | ENST00000230449.9 | c.2260G>C | p.Glu754Gln | missense_variant | 23/28 | 1 | NM_018303.6 | ENSP00000230449.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000428 AC: 1AN: 233710Hom.: 0 AF XY: 0.00000789 AC XY: 1AN XY: 126682
GnomAD4 exome AF: 0.00000900 AC: 13AN: 1444644Hom.: 0 Cov.: 30 AF XY: 0.00000974 AC XY: 7AN XY: 718320
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2024 | The c.2260G>C (p.E754Q) alteration is located in exon 23 (coding exon 22) of the EXOC2 gene. This alteration results from a G to C substitution at nucleotide position 2260, causing the glutamic acid (E) at amino acid position 754 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at